Core Laboratories
CLB
383 hedge funds and large institutions have $5.71B invested in Core Laboratories in 2016 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 131 increasing their positions, 129 reducing their positions, and 37 closing their positions.
59% more first-time investments, than exits
New positions opened: 59 | Existing positions closed: 37
52% more call options, than puts
Call options by funds: $40.4M | Put options by funds: $26.6M
14% more capital invested
Capital invested by funds: $5.01B → $5.71B (+$697M)
5% more funds holding
Funds holding: 365 → 383 (+18)
2% more repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 129
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
1.2% less ownership
Funds ownership: 104.6% → 103.41% (-1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$84.8M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$46.3M |
| 3 |
Renaissance Technologies
New York
|
+$29.1M |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$26.2M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
-$41.4M |
| 2 |
WP
Wedgewood Partners
St Louis,
Missouri
|
-$32.1M |
| 3 |
Morgan Stanley
New York
|
-$26.3M |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$16M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15M |
CLB Hedge Fund Activity: Q2 2016 in Review
383 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2016, worth a combined $5.71B — up 14% from $5.01B a quarter earlier.
Buyers outnumbered sellers: 59 funds opened new CLB positions and 37 closed out — a net gain of 22 holders — while 131 added to existing stakes and 129 trimmed.
The largest buyer was Macquarie Group, adding an estimated $84.8M. The largest seller was EARNEST Partners, cutting an estimated $41.4M.
- 383 institutional investors held Core Laboratories (CLB) as of Q2 2016, up from 365 in Q1 2016.
- Funds reported $5.71B of Core Laboratories stock for Q2 2016, up 14% quarter-over-quarter.
- 59 funds opened new Core Laboratories positions in Q2 2016 and 37 closed out, a net change of +22 holders.
- The largest Core Laboratories buyer in Q2 2016 was Macquarie Group, an estimated $84.8M added.
- The largest Core Laboratories seller in Q2 2016 was EARNEST Partners, an estimated $41.4M sold.
Based on aggregated 13F filings for Q2 2016.